During the past decade, Universitätsklinikum Ulm conducted 307 clinical trials. In the 10-year time frame, 307 clinical trials started and 118 clinical trials were completed, i.e. on average, 38.4% percent of trials that started reached the finish line to date. In the past 5 years, 140 clinical trials started and 77 clinical trials were completed. i.e. 55% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Ulm" #1 sponsor was "University of Ulm" with 26 trials, followed by "Boehringer Ingelheim" with 24 trials sponsored, "Celgene" with 21 trials sponsored, "Janssen Research & Development, LLC" with 17 trials sponsored and "Pfizer" with 17 trials sponsored. Other sponsors include 359 different institutions and companies that sponsored additional 210 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Ulm" #1 collaborator was "Eli Lilly and Company" with 8 trials as a collaborator, "Hoffmann-La Roche" with 7 trials as a collaborator, "Charite University, Berlin, Germany" with 6 trials as a collaborator, "University Hospital Ulm" with 6 trials as a collaborator and "ClinAssess GmbH" with 5 trials as a collaborator. Other collaborators include 274 different institutions and companies that were collaborators in the rest 221 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Ulm" are "Acute Myeloid Leukemia" (18 trials), "Ulcerative Colitis" (16 trials), "Crohn Disease" (12 trials), "Myelodysplastic Syndromes" (11 trials) and "Amyotrophic Lateral Sclerosis" (9 trials). Many other conditions were trialed in "Universitätsklinikum Ulm" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Ulm" are "Drug" (353 trials), "Device" (48 trials), "Other" (44 trials), "Biological" (33 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (98 trials), "Azacitidine" (12 trials), "Gemcitabine" (11 trials), "Cytarabine" (10 trials) and "Obinutuzumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Ulm" are 443 trials for "All" genders, 13 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 181 active trials in "Universitätsklinikum Ulm". 2 are not yet recruiting, 95 are recruiting, 83 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 201 completed trials in Universitätsklinikum Ulm, undefined suspended trials, and 53 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Ulm, 38 "Phase 1" clinical trials were conducted, 160 "Phase 2" clinical trials and 179 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 40 trials that are defined as “Not Applicable".

Universitätsklinikum Ulm has several departments that took part in Clinical trials: "Universitätsklinikum Ulm; Medizinische Uni-Klinik III Abt. Innere Medizin III Hämatologie u. Onkolo." - 26 trials, "Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm" - 23 trials, "Universitätsklinikum Ulm; Klinik für Urologie" - 6 trials, "Universitätsklinikum Ulm, Klinik für Neurologie" - 33 trials, "University Children's Hospital" - 5 trials, "Universitatsklinikum Ulm, Klinik fur Innere Medizin II" - 4 trials, "Clinic of Anesthesiology" - 3 trials, "Universitätsklinikum Ulm Zentrum für Innere Medizin" - 30 trials, "Zentrum für Innere Medizin Uni Ulm" - 2 trials, "Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin, Päd. Hämatologie und Onkologie" - 2 trials, "University of Ulm, Dept. of Visceral Surgery" - 2 trials, "University of Ulm, Memory Clinic" - 2 trials, "Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Ulm" - 2 trials